Safety and Effectiveness of Regorafenib
NCT02042144
·
clinicaltrials.gov ↗
COMPLETED
Status
1034
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
Stivarga (Regorafenib, BAY73-4506)
Sponsor
Bayer